CareLit · DOI-Nachweis · Aktuelle Urologie
Final Report on Low-Dose Estramustine Phosphate (EMP) Monotherapy and Very Low-Dose EMP Therapy combined with LH-RH Agonist for Previously Untreated Advanced Prostate Cancer
DOI 10.1055/s-0029-1224657
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT. Kitamura, M. Suzuki, H. Nishimatsu, T. Kurosaki, Y. Enomoto, H. Fukuhara, H. Kume, T. Takeuchi, L. Miao, H. Jiangang, L. Xiaoqiang
ZeitschriftAktuelle Urologie
AusgabeS 01/2010
Jahrgang / SeitenJg. 41 · S. S34-S40
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract PURPOSE: In order to assess the efficacy and toxicity of oral estramustine phosphate (EMP) administration, low-dose EMP monotherapy (study 1) and very low-dose EMP therapy with luteinizing hormone-releasing hormone (LH-RH) agonist (study 2) were conducted in previously untreated prostate cancer and long-term outcomes were compared between the 2 study groups. MATERIALS AND METHODS: Studies 1 and 2 were inde…
Zitieren
Zitierempfehlung
T. Kitamura, M. Suzuki, H. Nishimatsu, T. Kurosaki, Y. Enomoto, H. Fukuhara, H. Kume, T. Takeuchi, L. Miao, H. Jiangang, L. Xiaoqiang (2010) Final Report on Low-Dose Estramustine Phosphate (EMP) Monotherapy and Very Low-Dose EMP Therapy combined with LH-RH Agonist for Previously Untreated Advanced Prostate Cancer. Aktuelle Urologie, 41 (S 01), S34-S40. https://doi.org/10.1055/s-0029-1224657
Mit CareLit weiterarbeiten